Starpharma (ASX:SPL) share price jumps 7% on COVID variant update

This healthcare company is helping to fight the spread of COVID-19…

| More on:
covid asx share price represented by man in face mask giving thumbs up

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Starpharma Holdings Limited (ASX: SPL) share price is on course to end the week on a strong note.

At the time of writing, the dendrimer products developer's shares are up 7% to $1.66.

Why is the Starpharma share price pushing higher?

The Starpharma share price is pushing higher today after the company released another update on its COVID-fighting Viraleze antiviral nasal spray.

According to the release, new data demonstrates that the active ingredient in the Viraleze antiviral nasal spray, SPL7013, has been shown to be highly effective against various COVID-19 strains.

The release explains that SPL7013 achieved a more than 99.9% reduction of virus against the Alpha (UK), Beta (South Africa) and Gamma (Japan/Brazil) SARS-CoV-2 coronavirus variants of concern in laboratory-based virucidal assays. The testing of SPL7013 was conducted in the laboratory of virologist Professor Philippe Gallay at The Scripps Research Institute in the United States.

Management advised that SPL7013 virucidal activity against the Alpha, Beta and Gamma variants in the current assays were broadly consistent with the virucidal activity demonstrated in the US strain of SARS-CoV2 in the same assay.

It notes that within 30 seconds to 1 minute of exposure, SPL7013 achieved >99% reduction in infectious virus against Beta and Gamma variants, and >99.9% within 5 minutes. The Alpha variant was quicker, achieving a >99.9% reduction in infectious virus within 30 seconds to 1 minute of exposure.

Starpharma's CEO, Dr Jackie Fairley, commented: "We are very pleased to see such potent and rapid virucidal activity of Viraleze against multiple SARS-CoV-2 variants of concern, Alpha, Beta, and Gamma. These variants continue to spread across the globe and challenge efforts to control the COVID-19 pandemic."

"Given its broad spectrum of activity, Viraleze could prove to be particularly beneficial as an additional protective measure against these variants. This could prove particularly useful in settings where these variants can be problematic, like hotel quarantine and major international events such as the Tokyo Olympics," she concluded.

James Mickleboro does not own any shares mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Starpharma Holdings Limited. The Motley Fool Australia has recommended Starpharma Holdings Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Rocket takes off from the hand of a businessman.
Share Gainers

3 ASX 200 stocks rocketing higher in the first full trading week of 2026

Investors have been piling into these three ASX 200 stocks in 2026. But why?

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Codan, DroneShield, Mesoblast, and Woodside shares are storming higher today

These shares are ending the week strongly. But why?

Read more »

Woman with gold nuggets on her hand.
Gold

Up 177% in a year, why is this ASX 300 gold stock leaping higher again on Friday?

Investors are piling into this high-flying ASX gold stock again today. But why?

Read more »

a man in a green and gold Australian athletic kit roars ecstatically with a wide open mouth while his hands are clenched and raised as a shower of gold confetti falls in the sky around him.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors were in a good mood today.

Read more »

Man ecstatic after reading good news.
Share Gainers

Why Canyon Resources, Core Lithium, Duratec, and Unico Silver shares are storming higher

These shares are outperforming on Thursday. What's going on?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX was back in the green this Wednesday.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why 4DMedical, Regis Resources, Unico Silver, and WiseTech Global shares are pushing higher

These shares are having a good time on hump day. But why?

Read more »

A mature-aged woman wearing goggles and a red cape, rides her bike along the beach looking victorious.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a tough Tuesday for investors.

Read more »